Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

The role of frontal-subcortical circuits in the development of obsessive-compulsive disorders

https://doi.org/10.14412/2074-2711-2016-2-107-112

Full Text:

Abstract

The paper presents a concise review of investigations into the role of impaired frontal-subcortical circuits in the development of obsessive-compulsive disorder (OCD). It gives data on the frequency of neurosis-like symptoms of the OCD spectrum in neurological diseases.

The development of OCD is associated with an imbalance between the activity of the direct (activating) and indirect (inhibitory) pathways of the cortico-striatal-thalamo-cortical feedback loop. These data are confirmed by the results of neuroimaging and neuropsychological studies in patients with OCD. The frequency of OCD symptoms is high in organic brain lesions. OCP may be a manifestation of neurological diseases so their timely detection is an important aspect of a neurologist's work. The treatment of patients with neurosis-like disorders of the OCD spectrum within neurological diseases requires a multidisciplinary approach with the participation of a neurologist, a psychiatrist/psychotherapist, and a psychologist. It is necessary to combine pathogenetic treatment of the underlying disease and its neurosis-like manifestations. 

About the Author

M. A. Kutlubaev
G.G. Kuvatov Republican Clinical Hospital, Ufa; Bashkir State Medical University, Ministry of Health of Russia, Ufa
Russian Federation

Department of Neurology

Department of Neurology with Courses of Neurosurgery and Medical Genetics

132, Dostoevsky St., Ufa 450005, Bashkortostan

3, Lenin St., Ufa 450000, Bashkortostan 



References

1. Grant JE. Obsessive-compulsive disorder. N Engl J Med. 2014 Aug 14;371(7):646-53. doi: 10.1056/NEJMcp1402176.

2. Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014 Jun;15(6):410- 24. doi: 10.1038/nrn3746.

3. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000 Sep;23(3):563-86.

4. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012 Jan;16(1): 43-51. doi: 10.1016/j.tics.2011.11.003. Epub 2011 Dec 2.

5. Luxenberg JS, Swedo SE, Flament MF, et al. Neuroanatomical abnormalities in obsessive compulsive disorder determined with quantitative x-ray computed tomography. Am J Psychiatry. 1988 Sep;145(9):1089-93.

6. Robinson D, Wu H, Munne RA, Ashtari M, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995 May;52(5):393-8.

7. Burguiеre E, Monteiro P, Mallet L, et al. Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol. 2015 Feb;30:59-65. doi: 10.1016/ j.conb.2014.08.008. Epub 2014 Sep 19.

8. Baxter LR Jr. Neuroimaging studies of obsessive-compulsive disorder. Psychiatr Clin North Am. 1992 Dec;15(4):871-84.

9. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcorti￾cal circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26-37.

10. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-com￾pulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525-49. Epub 2007 Oct 17.

11. Fitzgerald KD, Welsh RC, Stern ER et al. Developmental alterations of frontal-striatalthalamic connectivity in obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):938-948.e3. doi: 10.1016/j.jaac. 2011.06.011. Epub 2011 Jul 31.

12. Koch K, Wagner G, Schachtzabel C, et al. White matter structure and symptom dimensions in obsessive-compulsive disorder. J Psychiatr Res. 2012 Feb;46(2):264-70. doi: 10.1016/j.jpsychires.2011.10.016. Epub 2011 Nov 17.

13. Harrison BJ, Pujol J, Cardoner N, et al. Brain corticostriatal system and the major clini￾cal symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry. 2013 Feb 15; 73(4):321-8. doi: 10.1016/j.biopsych.2012.10. 006. Epub 2012 Nov 28.

14. Brennan BP, Rauch SL, Jensen JE, Pope HG Jr. A critical review of magnetic resonance spectroscopy studies of obsessivecompulsive disorder. Biol Psychiatry. 2013 Jan 1;73(1):24-31. doi: 10.1016/j.biopsych. 2012.06.023. Epub 2012 Jul 24.

15. Rosenberg DR, MacMaster FP, Keshavan MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessivecompulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000 Sep;39(9):1096-103.

16. Burguiere E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science. 2013 Jun 7; 340(6137):1243-6. doi: 10.1126/science.1232380.

17. Pearlman DM, Vora HS, Marquis BG, et al. Anti-basal ganglia antibodies in primary obsessive-compulsive disorder: systematic review and meta-analysis. Br J Psychiatry. 2014 Jul;205(1): 8-16. doi: 10.1192/bjp.bp.113.137018.

18. Slattery MJ, Dubbert BK, Allen AJ, et al. Prevalence of obsessive-compulsive disorder in patients with systemic lupus erythematosus. J Clin Psychiatry. 2004 Mar;65(3):301-6.

19. Dougherty DD, Baer L, Cosgrove GR, et al. Prospective long-term follow up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry. 2002 Feb;159(2):269-75.

20. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 9th Ed.. Lippincott Williams & Wilkins; 2009. 4884 p.

21. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic-rate changes with both drug and behavior-therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992 Sep;49(9):681-9.

22. Saxena S, Brody AL, Maidment KM, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 1999 Dec;21(6):683-93.

23. Schwartz JM, Stoessel PW, Baxter LR Jr, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modifi￾cation treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996 Feb;53(2):109-13.

24. Freyer T, Klö ppel S, Tü scher O, et al. Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy. Psychol Med. 2011 Jan;41(1):207-16. doi: 10.1017/ S0033291710000309. Epub 2010 Mar 18.

25. Saxena S, Brody AL, Ho ML, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder versus major depression. Am J Psychiatry. 2003 Mar;160(3):522-32.

26. Saxena S, Gorbis E, O'Neill J, et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry. 2009 Feb;14(2):197-205. doi: 10.1038/sj.mp.4002134. Epub 2008 Jan 8.

27. de Koning PP, Figee M, van den Munckhof P, et al. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr Psychiatry Rep. 2011 Aug;13(4):274-82. doi: 10.1007/s11920- 011-0200-8.

28. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D cycloserine and the facilita￾tion of fear extinction and exposure therapy. Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.

29. Abramovitch, A, Dar R, Schweiger A, Hermesh H. Neuropsychological impairments and their association with obsessive-compulsive symptom severity in obsessive-compulsive disorder. Arch Clin Neuropsychol. 2011 Jun;26(4): 364-76. doi: 10.1093/arclin/acr022. Epub 2011 Apr 14.

30. Penadеs R, Catalаn R, Rubia K, et al. Impaired response inhibition in obsessive compulsive disorder. Eur Psychiatry. 2007 Sep;22(6):404-10.

31. Boone KB. Philpott L. Neuropsychological characteristics of nondepressed adults with obsessive-compulsive disorder. Cogn. Behav. Neurol. 1991;(4): 96-109.

32. Rao, NP, Reddy YC, Kumar KJ, et al. Are neuropsychological deficits trait markers in OCD? Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1574-9. doi: 10.1016/j.pnpbp.2008.05.026. Epub 2008 Jun 8.

33. Figee M, Vink M, de Geus F, et al. Dysfunctional reward circuitry in obsessivecompulsive disorder. Biol Psychiatry. 2011 May 1;69(9):867-74. doi: 10.1016/j.biopsych.2010. 12.003. Epub 2011 Jan 26.

34. Jung WH, Kang DH, Han JY, et al. Aberrant ventral striatal responses during incentive processing in unmedicated patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2011 May;123(5):376-86. doi: 10.1111/j.1600-0447.2010.01659.x. Epub 2010 Dec 22.

35. Bienvenu OJ, Samuels JF, Wuyek LA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012 Jan;42(1):1-13. doi: 10.1017/ S0033291711000742. Epub 2011 May 13.

36. Chamberlain SR, Fineberg NA, Menzies LA, et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007 Feb;164(2):335-8.

37. Rajender G, Bhatia MS, Kanwal K, et al. Study of neurocognitive endophenotypes in drug-naive obsessive-compulsive disorder patients, their first-degree relatives and healthy controls. Acta Psychiatr Scand. 2011 Aug;124(2):152-61. doi: 10.1111/j.1600- 0447.2011.01733.x. Epub 2011 Jun 16.

38. Jaafari N, Fernаndez de la Cruz L, Grau M, et al. Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis. Psychol Med. 2013 May;43(5): 1069-79. doi: 10.1017/S0033291712002012. Epub 2012 Aug 30.

39. Isaacs KL, Philbeck JW, Barr WB, et al. Obsessive-compulsive symptoms in patients with temporal lobe epilepsy. Epilepsy Behav. 2004 Aug;5(4):569-74.

40. Kaplan PW. Obsessive-compulsive disorder in chronic epilepsy. Epilepsy Behav. 2011 Nov;22(3):428-32. doi: 10.1016/j.yebeh. 2011.07.029. Epub 2011 Sep 1.

41. Foroughipour M, Behdani F, Hebrani P, et al. Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross￾sectional study. J Res Med Sci. 2012 Mar;17(3):248-53.

42. Tinelli E, Francia A, Quartuccio EM, et al. Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis. AJNR Am J Neuroradiol. 2013 Feb;34(2):305-9. doi: 10.3174/ajnr.A3210. Epub 2012 Jul 19.

43. Harbishettar V, Pal PK, Janardhan Reddy YC, Thennarasu K. Is there a relationship between Parkinson's disease and obsessive-compulsive disorder? Parkinsonism Relat Disord. 2005 Mar;11(2):85-8.

44. Alegret M, Junque C, Valldeoriola F, et al. Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):394-6.

45. Weintraub D. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S110-3. doi: 10.1016/S1353- 8020(09)70794-1.

46. Никитина АВ, Федорова НВ. Импульсивно-компульсивный синдром при болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013; (7 Вып. 2):32-8. [Nikitina AV, Fedorova NV. Impulsive-compulsive syndrome in Parkinson's disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;(7 Pt. 2):32-8. (In Russ.)].

47. Singer HS. Neurobiology of Tourette syndrome. Neurol Clin. 1997 May;15(2):357-79.

48. Wu MS, Horng B, Storch EA. A case report on obsessive-compulsive disorder and low-grade astrocytomas. Ann Clin Psychiatry. 2013 Nov; 25(4):309-10.

49. Kumar V, Chakrabarti S, Modi M, Sahoo M. Late-onset obsessive compulsive disorder associated with possible gliomatosis cerebri. World J Biol Psychiatry. 2009;10(4 Pt 2): 636-9. doi: 10.1080/15622970903036846.

50. Hegde A, Ghosh A, Grover S, et al. Arachnoid cyst masquerades as late onset obsessive-compulsive disorder. Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):125.e7-9. doi: 10.1016/j. genhosppsych.2013.09.002. Epub 2013 Oct 29.

51. Liu J, Zhang X, Liu J. Obsessions appear after the removal a brain tumor in the right frontal lobe. Gen Hosp Psychiatry. 2014 Jul-Aug;36(4):450.e3-4. doi: 10.1016/j.genhosppsych.2014.02.007. Epub 2014 Mar 5.

52. Rogers MP, Mendoza AY. Development of obsessive-compulsive disorder after brain tumor surgery and radiation. Psychosomatics. 1994 Jul-Aug;35(4):402-6.

53. Pewter SM, Williams WH, Haslam C, et al. Neuropsychological and psychiatric profiles in acute encephalitis in adults. Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):478-505.

54. Grados MA, Vasa RA, Riddle MA, et al. New onset obsessive-compulsive symptoms in children and adolescents with severe traumatic brain injury. Depress Anxiety. 2008;25(5):398-407.


For citation:


Kutlubaev M.A. The role of frontal-subcortical circuits in the development of obsessive-compulsive disorders. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2):107-112. (In Russ.) https://doi.org/10.14412/2074-2711-2016-2-107-112

Views: 401


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)